Quick Summary
Palnox 0.25mg Injection
Last updated on 31 Mar 2026 | 09:31 AM (IST)
₹124
MRP: ₹154.69
(You Save ₹30.69)
1 VIAL(s) OF 5ML
20% OFF
₹124
MRP: ₹154.69
Inclusive of all taxes
20% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Palonoget 0.25mg Injection
GLS PHARMA LTD
₹ 95.00/injection
23% cheaper
Themiset Injection
THEMIS MEDICARE...
₹ 129.00/injection
5% costlier
Palozest 0.25mg Injection
ZEE LABORATORIE...
₹ 150.00/injection
21% costlier
Pasetron 0.25mg Injection
UNITED BIOTECH ...
₹ 158.00/injection
28% costlier
Introduction to Palnox 0.25mg Injection
Palnox 0.25mg injection is an antiemetic drug belonging to the class of 5-HT3 receptor antagonists, containing the active ingredient Palonosetron. It is used to prevent and treat nausea, vomiting, or sickness caused by cancer treatments such as chemotherapy, radiotherapy, or after surgery. Nausea is characterised by stomach pain and the urge to vomit.
The common side effects that are likely to occur with this medicine are hives, swollen face, breathing trouble, and chest pain. Inform your healthcare provider if these side effects concern you or persist for longer than usual. It is given right away or later with anticancer medicines. It is usually given up to 24 hours while recovering from anesthesia after surgery.
Talk to your physician if you have a history of repeated constipation, blockage in the bowel, heart problems, or imbalance of certain minerals in your blood (such as magnesium and potassium). This medicine should not be used if you are allergic to this drug. Tell your physician about all the medications you have been taking recently, including herbal medicines and supplements, before taking the Palnox 0.25mg injection.
Uses of Palnox 0.25mg Injection
- Postoperative nausea and vomiting.
- Chemotherapy-induced nausea and vomiting.
Therapeutic Effects of Palnox 0.25mg Injection
It is a type of serotonin receptor antagonist, which works by blocking the action of serotonin in the body that induces nausea and vomiting. The chemotherapeutic trigger zone(CTZ) contains the receptor serotonin, when this CTZ is stimulated, vomiting occurs. It prevents the signals from serotonin and helps to reduce the symptoms of nausea and vomiting.
Interaction of Palnox 0.25mg Injection with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Palnox 0.25mg injection and reduce effectiveness by causing undesirable side effects.
More Information about Palnox 0.25mg Injection
- Store Palnox 0.25mg injection in the original package at room temperature (25°C). Do not freeze.
- Keep it out of reach from children and pets.
- It is important to get the dose at the scheduled time. If you missed the schedule, contact your doctor and reschedule the dose.
How to consume Palnox 0.25mg Injection
The medicine will be administered to you by a healthcare professional in a hospital setting. Palnox 0.25mg injection is usually given about 30 minutes before you receive your anti-cancer medicine (chemotherapy) or right before anaesthesia for surgery.
Safety Advice for Palnox 0.25mg Injection
Breast Feeding
It is not known if Palnox 0.25mg injection passes into your breast milk or if it will affect your baby or your breast milk. Please consult your doctor before breastfeeding.
Alcohol
It is unknown whether consuming alcohol interacts with Palnox 0.25mg injection. Please consult your doctor for more advice.
Liver
It is unknown whether Palnox 0.25mg injection can be administered to patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with this drug.
Lungs
It is not known whether Palnox 0.25mg injection can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Driving
It is unsafe to drive vehicles or operate heavy machinery after taking Palnox 0.25mg injection because it contains a small amount of alcohol which may cause dizziness and impair your concentration.
Pregnancy
It is unknown whether Palnox 0.25mg injection can be administered during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Side Effects of Palnox 0.25mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Hives
- Swollen face
- Breathing trouble
- Chest pain
Common
- Headache
- Fatigue
- Dizziness
- Abdominal pain
Word of Advice
Talk to your physician if you have a history of repeated constipation, blockage in the bowel, heart problems, or imbalance of certain minerals (such as potassium and magnesium) in your blood before taking Palnox 0.25mg injection. Inform your doctor or nurse if you are taking any medicines that affect your heartbeat because they could cause a heartbeat problem when taken with this injection.
FAQs about Palnox 0.25mg Injection
Q1.
What are the possible side effects of Palnox 0.25mg injection?
It can cause serious allergic reactions like hives, swollen face, breathing trouble, and chest pain. Some common side effects include headache and constipation.
Q2.
When should you take the Palnox 0.25mg injection?
The first dose of this drug is typically taken before the start of your surgery, chemotherapy, or radiation treatment.
Q3.
How does an Palnox 0.25mg injection work?
Palnox 0.25mg injection works by blocking the action of a chemical called serotonin, which is involved in causing nausea and vomiting.
Q4.
Who should not take an Palnox 0.25mg injection?
Palnox 0.25mg injection should not be taken by individuals who are allergic to it or its ingredients.
Q5.
What forms does the Palnox 0.25mg injection come in?
Palnox 0.25mg injection is available in the injection form.
Fact Box of Palnox 0.25mg Injection
Molecule name: Palonosetron | Therapeutic class: Antiemetics |
Pharmacological class: 5-HT3 receptor antagonists | Indications: 1.Postoperative nausea and vomiting. 2.Chemotherapy induced nausea and vomiting. |
References
- Helsinn Birex Pharmaceuticals Ltd, Electronic medicines compendium (EMC), [Revised on Dec 2021] [ Accessed on 01st March 2023], https://www.medicines.org.uk/emc/files/pil.513.pdf
- Fresenius Kabi, US Food and Drug Administration, [Revised on Dec 2018] [Accessed on 01st March 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208109s001lbl.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Treatment of disorders of bowel motility and water flux, 12th edition, 2011, 1341.
- KD Tripathi, Essentials of Medical Pharmacology, Antiemetic, prokinetic and digestant drugs, 7th edition, 2013, 669.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. B. Deiva
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:31 AM (IST)
Want to know more?
Read Our Editorial Policy
